...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method.
【24h】

Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method.

机译:使用共沉淀药物加载方法从阳极化纳米管钛中延长抗生素的递送。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Advances in nanotechnology have led to the development of novel orthopedic implant materials that not only have better cytocompatibility properties but can also be used as unique drug delivery platforms. In the present study, currently used titanium was anodized to possess nanotubular surface structures (80 nm inner diameter and 200 nm deep) capable of drug delivery. Such anodized nanotubular titanium surfaces promote bone cell functions (such as adhesion and differentiation) in vitro and in vivo compared with unanodized titanium. To achieve local drug delivery, anodized titanium with nanotubular structures were loaded with penicillin-based antibiotics using a co-precipitation method in which drug molecules were mixed in simulated body fluid to collectively precipitate with calcium phosphate crystals. Results showed for the first time that such co-precipitated coatings on anodized nanotubular titanium could release drug molecules for up to 3 weeks whereas previous studies have demonstrated only a 150-minute release of antibiotics through simple physical adsorption. Furthermore, drug release using co-precipitation from anodized nanotubular titanium was determined to be a diffusion process dependent on first-order kinetics. In addition, contrary to conventional thinking that penicillin-based drug release should decrease cell functions (including both bacteria and mammalian cells), results of this study showed similar osteoblast (bone-forming cell) adhesion between non-drug loaded and drug loaded precipitated calcium phosphate coatings on anodized titanium. Due to the above, these findings represent a promising surface treatment for titanium that could be used for local drug delivery for improving orthopedic applications and, thus, should be studied further.
机译:纳米技术的进步导致了新型骨科植入物材料的开发,该材料不仅具有更好的细胞相容性,而且还可以用作独特的药物递送平台。在本研究中,对当前使用的钛进行了阳极氧化处理,使其具有能够传递药物的纳米管表面结构(内径80 nm,深200 nm)。与未阳极氧化的钛相比,此类阳极氧化的纳米管钛表面在体外和体内可促进骨细胞功能(例如粘附和分化)。为了实现局部药物递送,使用共沉淀法将具有青霉素基抗生素的纳米管结构的阳极氧化钛加载到其中,将药物分子混合在模拟体液中以与磷酸钙晶体共同沉淀。结果首次表明,这种在阳极氧化纳米管钛上的共沉淀涂层可以释放药物分子长达3周,而以前的研究表明,仅通过简单的物理吸附就可以释放抗生素150分钟。此外,使用共沉淀法从阳极氧化纳米管钛中释放药物被确定为取决于一级动力学的扩散过程。此外,与传统的以青霉素为基础的药物释放会降低细胞功能(包括细菌和哺乳动物细胞)的传统想法相反,该研究结果表明,非药物负载和药物负载沉淀钙之间的成骨细胞(成骨细胞)粘附相似阳极氧化钛上的磷酸盐涂层。由于上述原因,这些发现代表了钛的有前途的表面处理技术,该表面处理技术可用于局部药物递送以改善整形外科应用,因此应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号